CT-388

CT-388 is an investigational dual GLP-1/GIP receptor agonist developed for metabolic conditions. Researchers are studying its potential for weight management and blood sugar regulation.

In the literature, CT-388 appears most often in work focused on weight loss, fat loss and blood sugar. Studies in this area tend to look at mechanisms and observed effects in laboratory and preclinical settings rather than outcomes in people, so the picture is best read as a map of where researchers have been curious — not as evidence of any benefit.

Because it is catalogued here under powder peptides, CT-388 also shows up in discussions of metabolism. Coverage across those topics varies widely in quality and depth, and much of it is early-stage. Reading the underlying research directly is the only way to judge how strong any particular finding is.